NEW YORK, Jan. 27 (GenomeWeb News) - Affymetrix shares were down 6.97 percent, or $2.78, at $37.35 in afternoon trading after the company posted an 8.2-percent decline in fourth-quarter profits.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.